The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

The biosimilar will be available to any licensed specialty pharmacy in the United States at a 95% discount from Stelara, starting January 1, 2026.

Large language models (LLMs) were more likely to suggest inferior treatment options when reviewing hypothetical cases when ...

National registry study finds overall survival improved across the board after the introduction of immune checkpoint ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

New research highlights the potential risks of skipping nasogastric tubes after esophageal surgery, suggesting they may reduce anastomotic leak rates. Skipping the use of a nasogastric (NG) tube after ...

COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.

New study results provide insight into improving heart health through behavior changes, such as taking standing breaks ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...